Form 4 Filing for C4 Therapeutics, Inc. - Hughes Owen

This filing details a Form 4 submission for C4 Therapeutics, Inc. (CCCC), concerning reporting owner Hughes Owen. On June 24, 2026, Owen acquired 62,000 stock options with a right to buy at a price of $0.00 per share. These options are set to vest on June 24, 2027, or the next annual stockholder meeting, provided Owen remains on the Board. The underlying security is Common Stock, and post-transaction, Owen holds 62,000 shares. The filing also notes a conversion or exercise price of $4.25 for these options.